NorthWest Biotherapeutics Inc (NWBO)

[Virgilio]

I think we got the answer to this question at the ASM when Linda said they were doing a blinded sweep of data (however she put it) every spring since 2015 and would do one again this spring, and she indicated a chance of ending the trial after this spring refresh.

Many investors couldn't attend the ASM, and they only rely on PR's and 8Ks. If anything has changed, I believe it would be nice to know.

Patients were living longer. Have we heard that before?

Yes, I believe, at the SSF 2016, but if I recall correctly some other consideration was added to that statement.

ASCO designation for a great immunotherapy trial result, as Flipper share with us the other day

A link would be welcomed (seriously missed it).

I take that to mean that they didn’t get it 100% correct, but it was close enough

I take it as "someone believes it's that way and we don't want to either encourage nor discourage that point of view". Neutral view in my opinion, so basically IMO not helpful at this/that time.